Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

0.885
+0.0050.57%
Volume:325.50K
Turnover:281.52K
Market Cap:638.97M
PE:-2.45
High:0.895
Open:0.880
Low:0.850
Close:0.880
52wk High:2.340
52wk Low:0.835
Shares:722.00M
HK Float Shares:722.00M
Volume Ratio:0.48
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.361
ROE:-7.67%
ROA:-7.02%
PB:0.25
PE(LYR):-2.45
PS:15.65

Loading ...

Brii Biosciences Completes HK$0.03 Million Share Buyback, Boosts Treasury Stock to 13.05 Million Shares

Bulletin Express
·
Sep 18

BRII-B (02137) Spends HK$25,800 on Share Buyback on September 18

Stock News
·
Sep 18

Brii Bio (BRII-B) H1 2026: Loss Narrows 32%, RMB1.77 Billion Cash Extends Runway to 2029

Bulletin Express
·
Sep 17

Brii Bio Releases 2026 Interim Report Online; Shareholders May Request Printed Copies

Bulletin Express
·
Sep 17

Brii Bio Posts 2026 Interim Report Online and Details Shareholder Communication Arrangements

Bulletin Express
·
Sep 17

BRII-B Executes HK$0.09 Million Share Buyback, Reducing Outstanding Shares by 0.01%

Bulletin Express
·
Sep 16

BRII-B (02137) Allocates HK$86,000 for Share Buyback on September 16

Stock News
·
Sep 16

Brii Biosciences Completes Additional Share Buyback; Treasury Stock Rises to 12.92 Million Shares

Bulletin Express
·
Aug 31

Brii Biosciences Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Aug 31

HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%

Tiger Newspress
·
Aug 26

Brii Bio Repurchases 120,000 Shares; Treasury Stock Rises to 12.90 Million

Bulletin Express
·
Aug 25

Brii-Biosciences (BRII-B) Issues 0.26 Million New Shares Under Employee Schemes; Repurchases 0.06 Million Shares Into Treasury

Bulletin Express
·
Aug 24

BRII-B (02137) Buys Back 60,000 Shares for HK$60,300 on August 24

Stock News
·
Aug 24

Brii Biosciences Files HKEX Next-Day Disclosure, Lifts Share Capital by 255,793 Shares

Reuters
·
Aug 24

Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business

Reuters
·
Aug 24

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Aug 22

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

Reuters
·
Aug 21

Hong Kong Stock Market Flash: BRII-B Surges Over 8% as Interim Loss Narrows 32.08% and Promising Clinical Data Emerges

Stock News
·
Aug 21

China's Brii Biosciences Interim Net Loss Narrows on Lower R&D Expenses

Reuters
·
Aug 21

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

THOMSON REUTERS
·
Aug 21